Rhein, an inhibitor of adipocyte differentiation and adipogenesis

Journal of Asian Natural Products Research

Volumn 13, Issue 8, 2011, Pages 714-723

  Liu, Qian ^a   Zhang, Xiao Lin ^a   Tao, Rong Ya ^a   Niu, Ya Jing ^a   Chen, Xiao Guang ^a   Tian, Jin Ying ^a   Ye, Fei ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

3T3 L1; Adipocyte differentiation; Adipogenesis; Rhein

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A OXIDASE; CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; CD36 ANTIGEN; FATTY ACID SYNTHASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RHEIN;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; LIPID DIET; MALE; METABOLIC DISORDER; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; UPREGULATION; WEIGHT GAIN;

3T3-L1 CELLS; ACETYL-COA CARBOXYLASE; ADIPOCYTES; ADIPOSITY; ANIMALS; ANTHRAQUINONES; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL DIFFERENTIATION; DRUGS, CHINESE HERBAL; MICE; MICE, INBRED C57BL; OBESITY; PPAR GAMMA;

MUS; RODENTIA;

EID: 79960508980     PISSN: 10286020     EISSN: 14772213     Source Type: Journal    
DOI: 10.1080/10286020.2011.586341     Document Type: Article

References (20)

1. B. M. Spiegelman and J. S. Flier, Cell 104, 531 (2001).
2. D. Haslam, Primary Care Diabetes 4, 105 (2010).
3. A. Must, J. Spadano, E. H. Coakley, A. E. Field, G. Colditz, and W. H. Dietz, Jama 282, 1523 (1999).
4. G. Frühbeck, Methods Mol. Biol. 456, 1 (2008).
5. H. Green and O. Kehinde, Cell 5, 19 (1975).
6. H. Green and M. Meuth, Cell 3, 127 (1974).
7. P. Cornelius, O. A. MacDougald, and M. D. Lane, Annu. Rev. Nutr. 14, 99 (1994).
8. Q. Q. Tang, T. C. Otto, and M. D. Lane, Proc. Natl Acad. Sci. USA 100, 850 (2003).
9. Z. Wu, N. L. Bucher, and S. R. Farmer, Mol. Cell Biol. 16, 4128 (1996).
10. E. D. Rosen, C. J. Walkey, P. Puigserver, and B. M. Spiegelman, Genes Dev. 14, 1293 (2000).
11. Z. Wu, E. D. Rosen, R. Brun, S. Hauser, G. Adelmant, A. E. Troy, C. McKeon, G. J. Darlington, and B. M. Spiegelman, Mol. Cell 3, 151 (1999).
12. L. Samuelsson, K. Stromberg, K. Vikman, G. Bjursell, and S. Enerback, Embo J. 10, 3787 (1991).
13. M. Z. Guo, X. S. Li, H. R. Xu, Z. C. Mei, W. Shen, and X. F. Ye, Acta Pharma. Sin. 23, 739 (2002).
14. S. Miccadei, R. Pulselli, and A. Floridi, Anticancer Res. 13, 1507 (1993).
15. X. H. Guo, Z. H. Liu, C. S. Dai, H. Li, D. Liu, and L. S. Li, Acta Pharma. Sin. 22, 934 (2001).
16. Z. H. Jia, Z. H. Liu, J. M. Zheng, C. H. Zeng, and L. S. Li, Exp. Clin. Endocrinol. Diabetes 115, 571 (2007).
17. J. M. Zheng, J. M. Zhu, L. S. Li, and Z. H. Liu, Br. J. Pharmacol. 153, 1456 (2008).
18. S. B. Choi, B. S. Ko, S. K. Park, J. S. Jang, and S. Park, Life Sci. 78, 934 (2006).
19. S. Miccadei, R. Pulselli, and A. Floridi, Anticancer Res. 13, 1507 (1993).
20. W. N. Cong, R. Y. Tao, J. Y. Tian, G. T. Liu, and F. Ye, Life Sci. 82, 983 (2008).